US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
カナダ
TSXV
ImmunoPrecise Antibodies Ltd (IPA)
ImmunoPrecise Antibodies Ltd (IPA) ニュース

IPA

ImmunoPrecise Antibodies (IPA)

ImmunoPrecise Antibodies Ltd

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:TSXV:IPA

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2022/05/09	22 : 18	InvestorsHub NewsWire	IPA's Subsidiary BioStrand Secures Second VLAIO Research Grant	TSXV:IPA	ImmunoPrecise Antibodies Ltd
2022/04/14	21 : 06	InvestorsHub NewsWire	IPA Completes Acquisition of Belgian Technology Companies BioStrand, BioKey, and BioClue - Adding Artificial Intelligence-Driven Analytics to its Antibody Discovery Capabilities and Offerings	TSXV:IPA	ImmunoPrecise Antibodies Ltd
2022/03/30	00 : 48	InvestorsHub NewsWire	IPA Announces Agreement to Acquire BioStrand BV - Revolutionizing Biotherapeutics with Methodology to Encode Omics and Power Drug Development with Advanced Artificial Intelligence	TSXV:IPA	ImmunoPrecise Antibodies Ltd
2022/03/14	22 : 04	InvestorsHub NewsWire	IPA Selected to Work with Elektrofi on COVID-19 Therapeutic Delivery and Future Pandemic Preparation under SBIR Contract from Defense Health Agency within US Department of Defense	TSXV:IPA	ImmunoPrecise Antibodies Ltd
2022/03/09	22 : 07	InvestorsHub NewsWire	IPA Updates on Investigational New Drug (IND) Enabling Program for PolyTope® TATX-03	TSXV:IPA	ImmunoPrecise Antibodies Ltd
2021/04/08	21 : 08	InvestorsHub NewsWire	ImmunoPrecise Launches TATX-112 Candidate Antibody Program, for the Treatment of Cancer and Alzheimer's Disease	TSXV:IPA	ImmunoPrecise Antibodies Ltd
2021/02/13	15 : 25	PR Newswire (Canada)	TSX Venture Exchange Stock Maintenance Bulletins	TSXV:IPA	ImmunoPrecise Antibodies Ltd
2020/12/23	21 : 30	PR Newswire (Canada)	ImmunoPrecise Antibodies to Begin Trading on Nasdaq Stock Exchange	TSXV:IPA	ImmunoPrecise Antibodies Ltd
2020/12/21	22 : 12	PR Newswire (Canada)	ImmunoPrecise Reports Financial Results and Recent Business Highlights for Second Quarter of 2021 Fiscal Year	TSXV:IPA	ImmunoPrecise Antibodies Ltd
2020/12/14	21 : 20	PR Newswire (Canada)	ImmunoPrecise and LiteVax Advance SARS-CoV-2 Vaccine Candidate	TSXV:IPA	ImmunoPrecise Antibodies Ltd
2020/12/11	21 : 45	PR Newswire (Canada)	ImmunoPrecise Collaboration Enables Preclinical Manufacturing of Lead Antibodies Targeting SARS-CoV-2	TSXV:IPA	ImmunoPrecise Antibodies Ltd
2020/11/26	03 : 46	PR Newswire (Canada)	ImmunoPrecise Antibodies Ranked Number 240 Fastest-Growing Company in North America on Deloitte's 2020 Technology Fast 500™	TSXV:IPA	ImmunoPrecise Antibodies Ltd
2020/11/23	21 : 00	PR Newswire (Canada)	IPA Selects Polytope™ Formulations for Pre-Clinical Studies	TSXV:IPA	ImmunoPrecise Antibodies Ltd
2020/11/19	21 : 00	PR Newswire (Canada)	ImmunoPrecise and Genmab Enter into a Technology Partnership Targeting Infectious Disease	TSXV:IPA	ImmunoPrecise Antibodies Ltd
2020/11/18	10 : 01	PR Newswire (Canada)	ImmunoPrecise Antibodies Confirms Effective Date of Share Consolidation	TSXV:IPA	ImmunoPrecise Antibodies Ltd
2020/11/09	23 : 11	PR Newswire (Canada)	ImmunoPrecise Antibodies Files Preliminary Base Shelf Prospectus and Registration Statement	TSXV:IPA	ImmunoPrecise Antibodies Ltd
2020/11/05	09 : 08	PR Newswire (Canada)	ImmunoPrecise Antibodies to Complete Share Consolidation in Preparation for Potential Nasdaq Listing	TSXV:IPA	ImmunoPrecise Antibodies Ltd
2020/11/03	21 : 30	PR Newswire (Canada)	ImmunoPrecise Antibodies and Mila Announce Strategic AI Partnership	TSXV:IPA	ImmunoPrecise Antibodies Ltd
2020/10/27	20 : 28	PR Newswire (Canada)	ImmunoPrecise and Twist Bioscience Announce Collaboration for the Creation of Novel, Therapeutic Products	TSXV:IPA	ImmunoPrecise Antibodies Ltd
2020/10/08	20 : 30	PR Newswire (Canada)	IPA Delivers Lead Candidate Antibodies from B Cell Select™ Platform for at Home SARS-CoV-2 Diagnostic Test	TSXV:IPA	ImmunoPrecise Antibodies Ltd
2020/10/06	20 : 30	PR Newswire (Canada)	IPA's CEO Dr. Jennifer Bath to Appear Live Wednesday on BNN Television	TSXV:IPA	ImmunoPrecise Antibodies Ltd
2020/10/05	20 : 30	PR Newswire (Canada)	ImmunoPrecise Antibodies CEO Dr. Jennifer Bath Appeared Live, Sunday October 4th, on Fox & Friends	TSXV:IPA	ImmunoPrecise Antibodies Ltd
2020/09/29	22 : 10	PR Newswire (Canada)	ImmunoPrecise Reports Revenue of $3.8 Million and Adjusted EBITDA of $932,000 for the First Quarter of Fiscal 2021	TSXV:IPA	ImmunoPrecise Antibodies Ltd
2020/09/29	00 : 59	PR Newswire (Canada)	IPA CEO Dr. Jennifer Bath to Appear Live Today on Bloomberg Television	TSXV:IPA	ImmunoPrecise Antibodies Ltd
2020/09/28	20 : 30	PR Newswire (Canada)	ImmunoPrecise to Present at the Virtual Gravitas Healthcare Investor Day	TSXV:IPA	ImmunoPrecise Antibodies Ltd
2020/09/25	20 : 30	PR Newswire (Canada)	ImmunoPrecise and LiteVax SARS-CoV-2 Vaccine Begins Pre-Clinical Trials	TSXV:IPA	ImmunoPrecise Antibodies Ltd
2020/09/22	20 : 30	PR Newswire (Canada)	IPA Europe Significantly Expands its Capabilities, Releasing its Second-Generation B Cell Select ™	TSXV:IPA	ImmunoPrecise Antibodies Ltd
2020/09/17	20 : 30	PR Newswire (Canada)	ImmunoPrecise Announces New Multi-Specific SARS-CoV-2 Antibody Collaboration with Zymeworks	TSXV:IPA	ImmunoPrecise Antibodies Ltd
2020/09/10	20 : 30	PR Newswire (Canada)	ImmunoPrecise Commences Application Process to Dual List on NASDAQ	TSXV:IPA	ImmunoPrecise Antibodies Ltd
2020/09/10	06 : 37	PR Newswire (Canada)	ImmunoPrecise Announces Participation at the H.C. Wainwright 22nd Annual Global Investment Conference on September 14-16, 202...	TSXV:IPA	ImmunoPrecise Antibodies Ltd

Showing the most relevant articles for your search:TSXV:IPA

1 2 3 4 5 6 次へ >>

Financial Select Sector

American Express

Deutsche Telekom (QX)

JP Morgan Chase

US Dollar vs Euro

US Dollar vs Sterling

Invesco QQQ Trust Series 1

Health Care Select Sector

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約